Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A Nanopore sequencing-based pharmacogenomic panel to personalize tuberculosis drug dosing

medRxiv(2023)10.1101/2023.09.08.23295248Source: DataRank Database

A Nanopore sequencing-based pharmacogenomic panel to personalize tuberculosis drug dosing is a research paper published in medRxiv (2023). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

refsnp

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: greenTopics (39)IDs (PubMed, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Késia Esther da Silva ORCID,Neesha Rockwood ORCID,Roeland E. Wasmann ORCID,Nombuso Yende,Taeksun Song ORCID

Live enrichment

PubMed:37732197 OpenAlex:https://openalex.org/W4386587330

Wellcome Trust

Grant: 203135

Centre for Infectious Diseases Research in Africa (CIDRI-Africa)

Wellcome Trust

Grant: unidentified

unidentified

National Institutes of Health

Grant: 5R21AI172182-02

Point-of-care pharmacogenomic testing to optimize isoniazid dosing for tuberculosis prevention

greenLicense: cc-by-nc-nd

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2023/09/10/2023.09.08.23295248.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2023.09.08.23295248

repositoryhttps://doi.org/10.1101/2023.09.08.23295248

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37732197

Fields of Study

Tuberculosis Research and EpidemiologyPharmacogenetics and Drug MetabolismCancer therapeutics and mechanisms0303 health sciences03 medical and health sciences

Keywords

PharmacogenomicsMinionSLCO1B1DosingDrugMedicinePharmacologyPharmacokineticsPharmacogeneticsSingle-nucleotide polymorphismIsoniazidDNA sequencingNanopore sequencingTuberculosisBiologyGeneticsGenotypeGeneMaleAdultAntitubercular AgentsInfectious DiseaseOriginal ArticlesMiddle AgedPolymorphism, Single NucleotideArticlePharmacogenomic TestingSouth AfricaYoung AdultHumansFemalePrecision MedicineRifampinGenetics & Genomics

Sustainable Development Goals

SDG 0: Good health and well-being